Open access · CC-BY
via OpenAlex
Endothelial–mitochondrial coupling in mitochondrial disease: A systematic review and quantitative synthesis of vascular, biochemical, and oxidative bioenergetic dysfunction
José A. Adams, Tiffany Ko, Laith R. Sultan, Tejas Sarna, Daniel E. McGinn, Arkady Uryash, Jose R. Lopez, Vinay Nadkarni, Rui Xiao, Marni J. Falk, Harry Ischiropoulos, Zarazuela Zolkipli‐Cunningham
Therapeutic Advances in Rare Disease · 2026
Abstract
Introduction: Mitochondrial diseases are multisystem disorders in which defects in oxidative phosphorylation disrupt cellular bioenergetics and redox signaling across the vasculature and heart. Because mitochondrial function is closely linked to endothelial nitric oxide (NO) production, we hypothesized that mitochondrial diseases manifest as a NO-deficiency endotheliopathy affecting conduit and microvascular function. To evaluate this, we performed a systematic review with quantitative synthesis of human studies reporting vascular reactivity, biochemical NO production, or myocardial metabolic imaging, aiming to define the magnitude of impairment and responsiveness to NO-precursor therapy (l-arginine or l-citrulline). Methods: ). Quantitative synthesis used Hedges g for between-group comparisons and standardized mean change (SMC) for within-subject responses. Risk of bias was evaluated using ROBINS-I and a modified Newcastle-Ottawa Scale. Results: Seven studies met these inclusion criteria, comprising 76 mitochondrial-disease subjects and 81 controls (ages 8-63 years). Across all vascular and metabolic domains, mitochondrial disease was associated with marked endothelial and bioenergetic impairment. Macro- and microvascular dysfunction, reflected by reduced FMD, RHI, and PLM hyperemia, demonstrated severe endothelium-specific abnormalities. Biochemical assays showed diminished NO synthesis. Myocardial PET imaging revealed reduced oxidative rate constants and increased energetic inefficiency despite preserved perfusion. Nitric oxide synthesis-precursor therapy was associated with improved endothelial reactivity (increased FMD, RHI, and ASR NOm) and significant, modest improvements in myocardial oxidative metabolism, consistent with partial restoration of endothelial NO signaling. Effect sizes collectively supported a reversible NO-deficiency endotheliopathy. The risk-of-bias assessment indicated moderate-to-good methodological quality, with limitations primarily related to small sample sizes and nonrandomized designs. Conclusions: Mitochondrial disease is characterized by significant impairments in vascular reactivity, NO signaling, and myocardial bioenergetics. Improvements in endothelial function and NO synthesis following l-arginine or l-citrulline supplementation are consistent with a role for impaired endothelial NO signaling in the vascular manifestations of mitochondrial disease. These findings highlight the vascular endothelium as a potential therapeutic target and underscore the need for future clinical intervention trials that use standardized vascular and bioenergetic endpoints.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1177/26330040261480132
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Adams, J.A., Ko, T., Sultan, L.R., Sarna, T., McGinn, D.E., Uryash, A., Lopez, J.R., Nadkarni, V., Xiao, R., Falk, M.J., Ischiropoulos, H., & Zolkipli‐Cunningham, Z. (2026). Endothelial–mitochondrial coupling in mitochondrial disease: A systematic review and quantitative synthesis of vascular, biochemical, and oxidative bioenergetic dysfunction. <em>Therapeutic Advances in Rare Disease</em>. https://doi.org/10.1177/26330040261480132
Vancouver
Adams JA, Ko T, Sultan LR, Sarna T, McGinn DE, Uryash A, et al. Endothelial–mitochondrial coupling in mitochondrial disease: A systematic review and quantitative synthesis of vascular, biochemical, and oxidative bioenergetic dysfunction. Therapeutic Advances in Rare Disease. 2026. doi:10.1177/26330040261480132.
BibTeX
@article{jos2026Endoth,
title = {Endothelial–mitochondrial coupling in mitochondrial disease: A systematic review and quantitative synthesis of vascular, biochemical, and oxidative bioenergetic dysfunction},
author = {José A. Adams and Tiffany Ko and Laith R. Sultan and Tejas Sarna and Daniel E. McGinn and Arkady Uryash and Jose R. Lopez and Vinay Nadkarni and Rui Xiao and Marni J. Falk and Harry Ischiropoulos and Zarazuela Zolkipli‐Cunningham},
journal = {Therapeutic Advances in Rare Disease},
year = {2026},
doi = {10.1177/26330040261480132},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2015
Open access · CC-BY
Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction
GeroScience 2026
Citation only
Targeting the NO-cGMP axis in age-related vascular dysfunction: a systematic review and meta-analysis of preclinical animal studies.
Current Opinion in Clinical Nutrition & Metabolic Care 2005
Citation only
Clinical aspects of coenzyme Q10: an update
Bipolar Disorders 2000
Open access · OA
Mitochondrial dysfunction in bipolar disorder
Molecular Genetics and Metabolism Reports 2019
Open access · CC-BY
Feasibility of cellular bioenergetics as a biomarker in porphyria patients
Journal of Neurochemistry 2015
Citation only